BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25767277)

  • 21. ETS transcription factors Etv2 and Fli1b are required for tumor angiogenesis.
    Baltrunaite K; Craig MP; Palencia Desai S; Chaturvedi P; Pandey RN; Hegde RS; Sumanas S
    Angiogenesis; 2017 Aug; 20(3):307-323. PubMed ID: 28108843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bee venom inhibits tumor angiogenesis and metastasis by inhibiting tyrosine phosphorylation of VEGFR-2 in LLC-tumor-bearing mice.
    Huh JE; Baek YH; Lee MH; Choi DY; Park DS; Lee JD
    Cancer Lett; 2010 Jun; 292(1):98-110. PubMed ID: 20188461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RALA-mediated delivery of FKBPL nucleic acid therapeutics.
    Bennett R; Yakkundi A; McKeen HD; McClements L; McKeogh TJ; McCrudden CM; Arthur K; Robson T; McCarthy HO
    Nanomedicine (Lond); 2015 Oct; 10(19):2989-3001. PubMed ID: 26419658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The somite-secreted factor Maeg promotes zebrafish embryonic angiogenesis.
    Wang X; Yuan W; Wang X; Qi J; Qin Y; Shi Y; Zhang J; Gong J; Dong Z; Liu X; Sun C; Chai R; Le Noble F; Liu D
    Oncotarget; 2016 Nov; 7(47):77749-77763. PubMed ID: 27780917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockage of VEGF-induced angiogenesis by preventing VEGF secretion.
    Björndahl M; Cao R; Eriksson A; Cao Y
    Circ Res; 2004 Jun; 94(11):1443-50. PubMed ID: 15192038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sprouty4 deficiency potentiates Ras-independent angiogenic signals and tumor growth.
    Taniguchi K; Ishizaki T; Ayada T; Sugiyama Y; Wakabayashi Y; Sekiya T; Nakagawa R; Yoshimura A
    Cancer Sci; 2009 Sep; 100(9):1648-54. PubMed ID: 19493272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Irradiation-induced angiogenesis through the up-regulation of the nitric oxide pathway: implications for tumor radiotherapy.
    Sonveaux P; Brouet A; Havaux X; Grégoire V; Dessy C; Balligand JL; Feron O
    Cancer Res; 2003 Mar; 63(5):1012-9. PubMed ID: 12615716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
    Li X; Wang X; Ye H; Peng A; Chen L
    Cancer Chemother Pharmacol; 2012 Sep; 70(3):425-37. PubMed ID: 22814678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancer.
    Annett S; Moore G; Short A; Marshall A; McCrudden C; Yakkundi A; Das S; McCluggage WG; Nelson L; Harley I; Moustafa N; Kennedy CJ; deFazio A; Brand A; Sharma R; Brennan D; O'Toole S; O'Leary J; Bates M; O'Riain C; O'Connor D; Furlong F; McCarthy H; Kissenpfennig A; McClements L; Robson T
    Br J Cancer; 2020 Feb; 122(3):361-371. PubMed ID: 31772325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Essential role of PDGFRalpha-p70S6K signaling in mesenchymal cells during therapeutic and tumor angiogenesis in vivo: role of PDGFRalpha during angiogenesis.
    Tsutsumi N; Yonemitsu Y; Shikada Y; Onimaru M; Tanii M; Okano S; Kaneko K; Hasegawa M; Hashizume M; Maehara Y; Sueishi K
    Circ Res; 2004 May; 94(9):1186-94. PubMed ID: 15059936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opposing effects of circadian clock genes bmal1 and period2 in regulation of VEGF-dependent angiogenesis in developing zebrafish.
    Jensen LD; Cao Z; Nakamura M; Yang Y; Bräutigam L; Andersson P; Zhang Y; Wahlberg E; Länne T; Hosaka K; Cao Y
    Cell Rep; 2012 Aug; 2(2):231-41. PubMed ID: 22884368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endogenous ribosomal protein L29 (RPL29): a newly identified regulator of angiogenesis in mice.
    Jones DT; Lechertier T; Reynolds LE; Mitter R; Robinson SD; Kirn-Safran CB; Hodivala-Dilke KM
    Dis Model Mech; 2013 Jan; 6(1):115-24. PubMed ID: 23118343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The therapeutic and diagnostic potential of FKBPL; a novel anticancer protein.
    Robson T; James IF
    Drug Discov Today; 2012 Jun; 17(11-12):544-8. PubMed ID: 22265918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The emerging role of FK506-binding proteins as cancer biomarkers: a focus on FKBPL.
    McKeen HD; Brennan DJ; Hegarty S; Lanigan F; Jirstrom K; Byrne C; Yakkundi A; McCarthy HO; Gallagher WM; Robson T
    Biochem Soc Trans; 2011 Apr; 39(2):663-8. PubMed ID: 21428958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Papp-a2 modulates development of cranial cartilage and angiogenesis in zebrafish embryos.
    Kjaer-Sorensen K; Engholm DH; Jepsen MR; Morch MG; Weyer K; Hefting LL; Skov LL; Laursen LS; Oxvig C
    J Cell Sci; 2014 Dec; 127(Pt 23):5027-37. PubMed ID: 25236600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis.
    Hiratsuka S; Maru Y; Okada A; Seiki M; Noda T; Shibuya M
    Cancer Res; 2001 Feb; 61(3):1207-13. PubMed ID: 11221852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel FK506-like binding protein interacts with the glucocorticoid receptor and regulates steroid receptor signaling.
    McKeen HD; McAlpine K; Valentine A; Quinn DJ; McClelland K; Byrne C; O'Rourke M; Young S; Scott CJ; McCarthy HO; Hirst DG; Robson T
    Endocrinology; 2008 Nov; 149(11):5724-34. PubMed ID: 18669603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opposite angiogenic outcome of curcumin against ischemia and Lewis lung cancer models: in silico, in vitro and in vivo studies.
    Fan S; Xu Y; Li X; Tie L; Pan Y; Li X
    Biochim Biophys Acta; 2014 Sep; 1842(9):1742-54. PubMed ID: 24970744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of Padi2 as a novel angiogenesis-regulating gene by genome association studies in mice.
    Khajavi M; Zhou Y; Birsner AE; Bazinet L; Rosa Di Sant A; Schiffer AJ; Rogers MS; Krishnaji ST; Hu B; Nguyen V; Zon L; D'Amato RJ
    PLoS Genet; 2017 Jun; 13(6):e1006848. PubMed ID: 28617813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor effects of 2-oxoglutarate through inhibition of angiogenesis in a murine tumor model.
    Matsumoto K; Obara N; Ema M; Horie M; Naka A; Takahashi S; Imagawa S
    Cancer Sci; 2009 Sep; 100(9):1639-47. PubMed ID: 19575748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.